Alvarez L, Guañabens N, Peris P, Monegal A, Bedini J L, Deulofeu R, Martinez de Osaba M J, Muñoz-Gomez J, Rivera-Fillat F, Ballesta A M
Service of Clinical Biochemistry, Hospital Clínic, University of Barcelona, Spain.
J Bone Miner Res. 1995 Mar;10(3):458-65. doi: 10.1002/jbmr.5650100318.
Clinical biochemical markers of bone turnover are usually increased in Paget's disease. However, the analysis of "new" markers, such as serum bone alkaline phosphatase (BAP), carboxy-terminal propeptide of type I procollagen (PICP), tartrate-resistant acid phosphatase (TRAP), telopeptide carboxy-terminal propeptide of type I collagen (ICTP), and urinary pyridinoline (PYR) and deoxipyridinoline (D-PYR), may improve the diagnostic efficacy and the evaluation of Paget's disease compared with conventional markers, such as serum total alkaline phosphatase (TAP) and urinary hydroxyproline (HYP). To evaluate the diagnostic accuracy and the changes of biochemical markers of bone turnover according to Paget's disease activity, we measured the levels of all these markers in three groups of pagetic patients classified according to their serum TAP activity: G-I, patients with serum TAP lower than 250 U/l (upper limit) (n = 15); G-II, patients with serum TAP between 251 and 500 U/l (n = 18); and G-III, patients with serum TAP greater than 501 U/l (n = 26). Serum TAP and BAP showed the highest diagnostic accuracy among the markers of bone formation with a sensitivity of 78% and 84%, respectively, when the specificity was 100%. Urinary PYR was the most sensitive marker of bone resorption. Also, urinary PYR showed the highest proportion of increased values in pagetic patients (73%) compared with urinary HYP (64%), urinary D-PYR (60%), serum ICTP (41%), or serum TRAP (39%). In pagetic patients with normal serum TAP activity (G-I), serum BAP concentration was increased in 60% of patients, and urinary PYR was increased in 40% of patients.(ABSTRACT TRUNCATED AT 250 WORDS)
骨转换的临床生化标志物在佩吉特病中通常会升高。然而,与传统标志物(如血清总碱性磷酸酶(TAP)和尿羟脯氨酸(HYP))相比,对“新型”标志物的分析,如血清骨碱性磷酸酶(BAP)、I型前胶原羧基末端前肽(PICP)、抗酒石酸酸性磷酸酶(TRAP)、I型胶原羧基末端端肽(ICTP)以及尿吡啶啉(PYR)和脱氧吡啶啉(D-PYR),可能会提高佩吉特病的诊断效能及评估效果。为了评估诊断准确性以及根据佩吉特病活动情况分析骨转换生化标志物的变化,我们在根据血清TAP活性分类的三组佩吉特病患者中测量了所有这些标志物的水平:第一组(G-I),血清TAP低于250 U/l(上限)的患者(n = 15);第二组(G-II),血清TAP在251至500 U/l之间的患者(n = 18);第三组(G-III),血清TAP大于501 U/l的患者(n = 26)。当特异性为100%时,血清TAP和BAP在骨形成标志物中显示出最高的诊断准确性,敏感性分别为78%和84%。尿PYR是骨吸收最敏感的标志物。此外,与尿HYP(64%)、尿D-PYR(60%)、血清ICTP(41%)或血清TRAP(39%)相比,尿PYR在佩吉特病患者中升高值的比例最高(73%)。在血清TAP活性正常的佩吉特病患者(G-I)中,60%的患者血清BAP浓度升高,40%的患者尿PYR升高。(摘要截选至250字)